Complications arise when assessing the evidence on anaemia in different conditions and with different causes (chronic kidney disease, uterine or postpartum bleeding, gastrointestinal disease, heart failure), using different comparators (oral iron, IV iron, placebo), and from patients receiving erythropoietin. The gene discussed is EPO; the disease is chronic kidney disease.